Jon M. Huntsman Receives American Cancer Society Meda...(t are not historical are forward-looking...),Health

Date:11/21/2008

t are not historical are forward-looking statements. These statements are based on management's current beliefs and expectations. The forward-looking statements in this release are subject to uncertainty and changes in circumstances and involve risks and uncertainties that may affect the company's operations, markets, products, services, prices and other factors as discussed in the Huntsman companies' filings with the U.S. Securities and Exchange Commission. Significant risks and uncertainties may relate to, but are not limited to, financial, economic, competitive, environmental, political, legal, regulatory and technological factors. In addition, the completion of any transactions described in this release is subject to a number of uncertainties and closing will be subject to approvals and other customary conditions. Accordingly, there can be no assurance that such transactions will be completed or that the company's expectations will be realized. The company assumes no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by applicable laws.

'/>"/>

SOURCE Huntsman Corporation Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2
Related medicine news :

1. The Honorable Edward M. Kennedy, Scientists Mina J. Bissell and Susan Band Horwitz, and Philanthropist Jon M. Huntsman to Receive American Cancer Society Highest Honor for Outstanding Contributions to Cancer Fight
2. Huntsman to Discuss Fourth Quarter and Full Year 2007 Results on Friday, February 22, 2008
3. Keryx Biopharmaceuticals Receives Nasdaq Notification
4. Kaiser Permanente Receives the Most Stars in California Office of Patient Advocates Annual Quality Report Card
5. Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q
6. Naviscan Receives 510(k) Clearance for Stereo Navigator(TM) - the First Commercially Available Breast PET-Guided Biopsy Feature
7. Mylan Receives Final FDA Approval for the Generic Version of the Antidepressant Sarafem(R) Pulvules(R) Capsules
8. Capital BlueCross Receives Prestigious Corporation of the Year Award
9. Bmc nurse manager receives Abstract Award
10. Cancer researcher receives $3.8 million award from US Department of Defense
11. Virginia Mental Health Hospital Improves Patient Comfort, Receives Award for Energy-Saving Renovations